相关实验视频

Updated: May 20, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

腹腔下血瘤对产妇抗脂综合征妊娠结果的影响

Rong Cang¹, Xuelei Ding¹, Zan Tian²

¹Department of Gynecological Endocrinology, The Fourth Hospital of Shijiazhuang (Obstetrics and Gynecology Hospital Affiliated to Hebei Medical University), Shijiazhuang, Hebei, People's Republic of China.

International journal of women's health

|March 24, 2025

概括

产科抗脂综合征 (OAPS) 患者的腹腔下血瘤 (SCH) 与更严重的免疫障碍和凝血病有关,增加了早产风险. 抗凝固药物治疗可能有助于使一些指标正常化.

科学领域:

产科和妇科产科和妇科
免疫学免疫学免疫学
血液学血液学血液学

背景情况:

产妇抗脂综合征 (OAPS) 对怀孕构成风险.
腹腔下血瘤 (SCH) 是OAPS怀孕中的潜在并发症.
了解SCH对OAPS结果的影响对于管理至关重要.

研究的目的:

为了研究产妇抗脂综合征 (OAPS) 患者的腹腔下血瘤 (SCH) 对怀孕结果的影响.
评估OAPSSCH.患者抗凝剂治疗的临床价值.
为了比较有SCH和没有SCH的OAPS患者之间的临床和实验室指标.

主要方法:

对109名OAPS患者进行了回顾性研究.
分为SCH (n=40) 和非SCH (n=69) 组.
基线数据的比较,实验室指标 (包括抗脂抗体,凝血标志物),并发症和怀孕结果.

主要成果:

两组之间堕胎或活产率没有显著差异.
在SCH组中,早产率 (34-37周) 显著更高 (13.7%对1.7%).
在SCH组中,三重阳性抗脂抗体的比例更高.
在治疗前,SCH组中的高血凝前标记 (β2GP I,LA,ACL,D-D,AA,ADP) 和较低的抗血凝标记 (ATIII,PS,PC) 在治疗前.
抗凝药疗法降低了一些标志物,但在SCH组治疗后,D-D和PS仍然较高.

结论:

在OAPS患者中,下血瘤表明更严重的免疫障碍和凝血病.
在OAPS怀孕中,SCH与早产风险增加有关.
实验室指标表明,即使在治疗后,SCH患者的凝血病仍然存在.

关键词:

抗凝固剂治疗是一种抗凝固剂治疗.产科抗脂综合征产科抗脂综合征过早分娩过早分娩底胆血瘤是一种底胆血瘤.

更多相关视频

Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye

Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye

Published on: September 5, 2011

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

相关概念视频

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...